Literature DB >> 2431888

VEPs in normal full-term and premature neonates: longitudinal versus cross-sectional data.

M J Taylor, R Menzies, L J MacMillan, H E Whyte.   

Abstract

VEPs have been shown to change with CNS maturation in children, yet few studies had documented maturational changes in the premature infant. Using LED goggles, VEPs were studied in 75 neurologically normal infants of 22-42 weeks gestational age (GA) within the first 3 days of life. Twenty of these (22-32 weeks GA) were also followed longitudinally. The 22-23 week GA neonates had no identifiable waves. In all infants greater than 24 weeks a large negative wave is seen with a latency around 300 msec (N300). After 27 weeks GA a late positive wave was present (P400), but with more variable latency and morphology. Between 30 and 35 weeks GA a small positive wave (P200) was seen in over one-third of the neonates; this component was present in all infants greater than 36 weeks GA. The consistency of the N300 across the ages studied suggests that it might arise from the basilar dendrites in the visual cortex, which are well developed by 24 weeks GA and undergo relatively little further development between 24 weeks and term. The P200 is suggested to arise from the apical dendrites which develop in the last trimester, explaining the emergence of P200 after 30 weeks GA. The infants followed longitudinally showed the same components, emerging in the same order, but with more rapid development (particularly of P200) compared to the cross-sectional studies. These data suggest that there are differences in the maturation of the visual system in the extrauterine versus intrauterine environment.

Entities:  

Mesh:

Year:  1987        PMID: 2431888     DOI: 10.1016/0168-5597(87)90066-9

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  16 in total

1.  Method of visual evoked potentials in the assessment of the condition of the central nervous systems in newborns.

Authors:  A M Kaz'min; A S Burkova; N I Kudashev; O E Ozerova
Journal:  Neurosci Behav Physiol       Date:  1990 Jul-Aug

2.  The effect of electrode position on flash visual evoked potentials in the newborn.

Authors:  B A Lupton; P K Wong; R Bencivenga; A Hill
Journal:  Doc Ophthalmol       Date:  1990-11       Impact factor: 2.379

3.  Flash visually evoked potentials in the newborn and their maturation during the first six months of life.

Authors:  Isabel Benavente; Pilar Tamargo; Natividad Tajada; Valentín Yuste; Ma Jesus Oliván
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

Review 4.  Use of evoked potentials in preterm neonates.

Authors:  M J Taylor; E Saliba; J Laugier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 5.  The human newborn's umwelt: Unexplored pathways and perspectives.

Authors:  Vanessa André; Séverine Henry; Alban Lemasson; Martine Hausberger; Virginie Durier
Journal:  Psychon Bull Rev       Date:  2018-02

6.  Effects of bilirubin on visual evoked potentials in term infants.

Authors:  Y J Chen; W M Kang
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

Review 7.  Multimodality evoked responses in the neurological assessment of the newborn.

Authors:  E Mercuri; K von Siebenthal; H Daniëls; F Guzzetta; P Casaer
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

8.  Pediatric clinical visual electrophysiology: a survey of actual practice.

Authors:  Anne B Fulton; Jelka Brecelj; Birgit Lorenz; Anne Moskowitz; Dorothy Thompson; Carol A Westall
Journal:  Doc Ophthalmol       Date:  2006-11-16       Impact factor: 2.379

9.  Chromatic and luminance contrast sensitivity in fullterm and preterm infants.

Authors:  Rain G Bosworth; Karen R Dobkins
Journal:  J Vis       Date:  2009-12-14       Impact factor: 2.240

Review 10.  Visual function in preterm infants: visualizing the brain to improve prognosis.

Authors:  Vann Chau; Margot J Taylor; Steven P Miller
Journal:  Doc Ophthalmol       Date:  2013-06-13       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.